Lv51
1085 积分 2021-02-07 加入
An Oral Interleukin-23–Receptor Antagonist Peptide for Plaque Psoriasis
2小时前
已完结
Prodrug Strategy to Address Impaired Oral Absorption of a Weakly Basic TYK2 Inhibitor Caused by a Gastric Acid-Reducing Agent
5天前
已完结
Targeted Protein Degradation Induced by HEMTACs Based on HSP90
9天前
已完结
Targeting the Tyrosine Kinase 2 (TYK2) Pseudokinase Domain: Discovery of the Selective TYK2 Inhibitor ABBV-712
13天前
已完结
Closing the Design–Make–Test–Analyze Loop: Interplay between Experiments and Predictions Drives PROTACs Bioavailability
13天前
已完结
Protein degraders push into novel target space
25天前
已完结
Triisobutylaluminium-Mediated Regioselective Protection of Sterically Hindered Amide NH of Cyclo-(AA-Gly): Key Building Block for Next-Generation Peptide Synthesis
25天前
已完结
TYK2: an emerging therapeutic target in rheumatic disease
26天前
已完结
Discovery of a Potent and Selective Tyrosine Kinase 2 Inhibitor: TAK-279
27天前
已完结
Discovery of Novel PROTAC-Based HPK1 Degraders with High Potency and Selectivity for Cancer Immunotherapy
28天前
已完结
皖公网安备34019202002308
